ELENA SASS: Open Payments
NPI 1437585031 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,280 in 45 payments from 7 companies in 2025. Trend: 2023 $2,577 · 2024 $2,321 · 2025 $2,280
Food & beverage: $2,280
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $511 |
| ABBVIE INC. | 21 | $428 |
| Otsuka America Pharmaceutical, Inc. | 6 | $406 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $358 |
| Axsome Therapeutics, Inc. | 3 | $275 |
| Janssen Pharmaceuticals, Inc | 2 | $160 |
| Alkermes, Inc. | 4 | $142 |
Products named: COBENFY, VRAYLAR, CAPLYTA, Auvelity, REXULTI, INVEGA SUSTENNA, ABILIFY MAINTENA, LYBALVI.
Industry payments across AZ — which companies pay providers there.
